EP Patent

EP1466628A1 — DHA-pharmaceutical agent conjugates

Assigned to American Regent Inc · Expires 2004-10-13 · 22y expired

What this patent protects

The invention provides conjugates of cis -docosahexaenoic acid and pharmaceutical agents useful in treating noncentral nervous system conditions. Methods for selectively targeting pharmaceutical agents to desired tissues are provided.

USPTO Abstract

The invention provides conjugates of cis -docosahexaenoic acid and pharmaceutical agents useful in treating noncentral nervous system conditions. Methods for selectively targeting pharmaceutical agents to desired tissues are provided.

Drugs covered by this patent

Patent Metadata

Patent number: EP1466628A1
Jurisdiction: EP
Classification: —
Expires: 2004-10-13
Drug substance claim: No
Drug product claim: No
Assignee: American Regent Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.